Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Wild

Showing results (111-120 of 128) with videos related to

Pageof 13
Sort By:
Cancer Biology & Therapy|January 30, 2013
Novel Hsp90 inhibitor NVP-AUY922 radiosensitizes prostate cancer cellsNishant Gandhi, Aaron T Wild, Sivarajan T Chettiar, et al.
Annals of Surgery|May 29, 2015
Reliable Detection of Somatic Mutations in Fine Needle Aspirates of Pancreatic Cancer With Next-generation Sequencing: Implications for Surgical ManagementVicente Valero, Tyler J Saunders, Jin He, et al.
JTO Clinical and Research Reports|September 30, 2021
Increasing Heart Dose Reduces Overall Survival in Patients Undergoing Postoperative Radiation Therapy for NSCLCAnnemarie F Shepherd, Anthony F Yu, Michelle Iocolano, et al.
International Journal of Surgical Oncology|July 26, 2012
Clinicopathologic Comparison of High-Dose-Rate Endorectal Brachytherapy versus Conventional Chemoradiotherapy in the Neoadjuvant Setting for Resectable Stages II and III Low Rectal CancerJessica A Smith, Aaron T Wild, Aatur Singhi, et al.
Journal of Gastrointestinal Oncology|April 2, 2015
Efficacy of platinum chemotherapy agents in the adjuvant setting for adenosquamous carcinoma of the pancreasAaron T Wild, Avani S Dholakia, Katherine Y Fan, et al.
International Journal of Radiation Oncology, Biology, Physics|October 1, 2013
Correlation of Smad4 status with outcomes in patients receiving erlotinib combined with adjuvant chemoradiation and chemotherapy after resection for pancreatic adenocarcinomaJoseph M Herman, Katherine Y Fan, Aaron T Wild, et al.
Journal of Gastrointestinal Oncology|December 3, 2013
Re-irradiation with stereotactic body radiation therapy as a novel treatment option for isolated local recurrence of pancreatic cancer after multimodality therapy: experience from two institutionsAaron T Wild, Susan M Hiniker, Daniel T Chang, et al.
International Journal of Radiation Oncology, Biology, Physics|February 13, 2016
Lymphocyte-Sparing Effect of Stereotactic Body Radiation Therapy in Patients With Unresectable Pancreatic CancerAaron T Wild, Joseph M Herman, Avani S Dholakia, et al.
Plos One|June 14, 2013
Concurrent versus sequential sorafenib therapy in combination with radiation for hepatocellular carcinomaAaron T Wild, Nishant Gandhi, Sivarajan T Chettiar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2013
Randomized phase III multi-institutional study of TNFerade biologic with fluorouracil and radiotherapy for locally advanced pancreatic cancer: final resultsJoseph M Herman, Aaron T Wild, Hao Wang, et al.
Pageof 13

Showing results (111-120 of 128) with videos related to

Sort By:
Pageof 13
Cancer Biology & Therapy|January 30, 2013
Novel Hsp90 inhibitor NVP-AUY922 radiosensitizes prostate cancer cellsNishant Gandhi, Aaron T Wild, Sivarajan T Chettiar, et al.
Annals of Surgery|May 29, 2015
Reliable Detection of Somatic Mutations in Fine Needle Aspirates of Pancreatic Cancer With Next-generation Sequencing: Implications for Surgical ManagementVicente Valero, Tyler J Saunders, Jin He, et al.
JTO Clinical and Research Reports|September 30, 2021
Increasing Heart Dose Reduces Overall Survival in Patients Undergoing Postoperative Radiation Therapy for NSCLCAnnemarie F Shepherd, Anthony F Yu, Michelle Iocolano, et al.
International Journal of Surgical Oncology|July 26, 2012
Clinicopathologic Comparison of High-Dose-Rate Endorectal Brachytherapy versus Conventional Chemoradiotherapy in the Neoadjuvant Setting for Resectable Stages II and III Low Rectal CancerJessica A Smith, Aaron T Wild, Aatur Singhi, et al.
Journal of Gastrointestinal Oncology|April 2, 2015
Efficacy of platinum chemotherapy agents in the adjuvant setting for adenosquamous carcinoma of the pancreasAaron T Wild, Avani S Dholakia, Katherine Y Fan, et al.
International Journal of Radiation Oncology, Biology, Physics|October 1, 2013
Correlation of Smad4 status with outcomes in patients receiving erlotinib combined with adjuvant chemoradiation and chemotherapy after resection for pancreatic adenocarcinomaJoseph M Herman, Katherine Y Fan, Aaron T Wild, et al.
Journal of Gastrointestinal Oncology|December 3, 2013
Re-irradiation with stereotactic body radiation therapy as a novel treatment option for isolated local recurrence of pancreatic cancer after multimodality therapy: experience from two institutionsAaron T Wild, Susan M Hiniker, Daniel T Chang, et al.
International Journal of Radiation Oncology, Biology, Physics|February 13, 2016
Lymphocyte-Sparing Effect of Stereotactic Body Radiation Therapy in Patients With Unresectable Pancreatic CancerAaron T Wild, Joseph M Herman, Avani S Dholakia, et al.
Plos One|June 14, 2013
Concurrent versus sequential sorafenib therapy in combination with radiation for hepatocellular carcinomaAaron T Wild, Nishant Gandhi, Sivarajan T Chettiar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2013
Randomized phase III multi-institutional study of TNFerade biologic with fluorouracil and radiotherapy for locally advanced pancreatic cancer: final resultsJoseph M Herman, Aaron T Wild, Hao Wang, et al.
Pageof 13